State Of Wyoming Annexon, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.73 - $11.94 $2,216 - $9,695	-812 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$11.49 - $22.0 $1,643 - $3,146	143 Added 21.38%	812 $9,000
Q3 2021 Feb 11, 2022	SELL	$16.35 - $23.4 $6,376 - $9,126	-390 Reduced 36.83%	669 $12,000
Q2 2021 Feb 11, 2022	BUY	$17.81 - $27.48 $11,434 - $17,642	642 Added 153.96%	1,059 $24,000
Q1 2021 Feb 08, 2022	BUY	$22.0 - $35.01 $9,174 - $14,599	417 New	417 $12,000

156

101M

3.73M

1.3M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $335M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.